New England Research & Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,915
| Closed | -$444K | – | 164 |
|
|
2024
Q2 | $444K | Buy |
+3,915
| New | +$444K | 0.21% | 133 |
|
|
2024
Q1 | – | Sell |
-2,950
| Closed | -$366K | – | 163 |
|
|
2023
Q4 | $366K | Buy |
+2,950
| New | +$366K | 0.19% | 128 |
|
|
2022
Q4 | – | Sell |
-2,590
| Closed | -$209K | – | 160 |
|
|
2022
Q3 | $209K | Buy |
+2,590
| New | +$209K | 0.13% | 150 |
|
|
2022
Q2 | – | Sell |
-1,840
| Closed | -$235K | – | 161 |
|
|
2022
Q1 | $235K | Hold |
1,840
| – | – | 0.12% | 144 |
|
|
2021
Q4 | $247K | Hold |
1,840
| – | – | 0.12% | 165 |
|
|
2021
Q3 | $252K | Sell |
1,840
-3,260
| -64% | -$446K | 0.13% | 156 |
|
|
2021
Q2 | $544K | Sell |
5,100
-100
| -2% | -$10.7K | 0.28% | 112 |
|
|
2021
Q1 | $467K | Hold |
5,200
| – | – | 0.26% | 106 |
|
|
2020
Q4 | $481K | Buy |
+5,200
| New | +$481K | 0.3% | 103 |
|
|
2019
Q2 | – | Sell |
-10,200
| Closed | -$304K | – | 169 |
|
|
2019
Q1 | $304K | Buy |
+10,200
| New | +$304K | 0.21% | 129 |
|